Results 71 to 80 of about 1,146,044 (291)
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source
Medical Record Storage System Based on Accreditation Criteria 3.8.4 in Public Health Centers
Sri Wahyuningsih Nugraheni +3 more
openalex +2 more sources
Interpretation and Misinterpretation of Medical Abbreviations Found in Patient Medical Records: A Cross-Sectional Survey [PDF]
Dineth C Jayatilake, Samson O Oyibo
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Dan Belletti1, Christopher Zacker1, C Daniel Mullins21Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 2University of Maryland School of Pharmacy, Baltimore, MD, USAAbstract: Health information technology (HIT) is engineered to promote ...
Dan Belletti +2 more
doaj
Prevalence and Determinant Analysis of Scabies Incidence in Rumak Village
Scabies is a global public health problem that affects millions of people worldwide, especially in crowded and underdeveloped places. Similar difficulties arise at Rumak Village, a rural community in West Lombok, where cramped living quarters ...
Idham Halid +2 more
doaj +1 more source
Evolving competencies to align electronic medical records – a dynamic resource-based perspective on hospitals' co-evolutionary information systems alignment capability [PDF]
Pien Walraven +4 more
openalex +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source

